✅گزارش واحد محتوایی موسسه آلند (دبیرخانه اجرایی فارمکس خاورمیانه) از چشم انداز بازار دارویی و آینده دارو در خاورمیانه

Published by: Pharmex Middle East (Aland Institute)

Region Covered: Middle East, North Africa, CIS, South Asia

The Middle East pharmaceutical sector is entering a period of accelerated transformation driven by population growth, increasing healthcare expenditure, government localization programs, and rising demand for Active Pharmaceutical Ingredients (APIs), machinery, and advanced manufacturing technologies.

Between 2024–2028, the pharmaceutical market in the Middle East is expected to grow at 8–12% CAGR, with Iran, Saudi Arabia, Egypt, the UAE, and Turkey forming the core of regional production and consumption.

1. Middle East Pharmaceutical Market – Regional Overview

Market Size

Middle East pharma market value (2024): ~USD 42 billion
Source: IQVIA Middle East Market Report 2024

Projected market size (2028): ~USD 60 billion

Key Drivers

Population across region: ~410 million

Strong demand for chronic disease treatments

Expansion of insurance coverage and state healthcare

API shortages leading to localization programs

Increased regulatory convergence (Saudi FDA, Iran IFDA, UAE MOH)

Top Markets in Production Capacity

1. Turkey – Finished dosage forms

2. Iran – APIs, biosimilars, and raw materials

3. Saudi Arabia – Localization programs (Vision 2030)

4. Egypt – Large consumer market

5. UAE – Regional logistics hub

2. API & Pharmaceutical Raw Materials Outlook

Global Context

The API market is dominated by:

India (32% global share)

China (28% global share)
Source: UNIDO API Industrial Assessment 2023

However, due to supply-chain disruptions (COVID, trade barriers, rising costs in India/China), Middle Eastern governments are aggressively investing in API localization.

Regional API Demand

Total API demand in Middle East (2024): USD 6.2 billion

Expected by 2028: USD 8.7 billion
Source: PharmaBoardroom MENA Market Insights 2024

Iran’s Role

Iran stands out as:

The largest producer of pharmaceutical APIs in the Middle East, with:

Over 70 API-producing companies

Export partners including India, Russia, Algeria, Iraq, Syria, Pakistan, Afghanestan

Strong competitive advantage in narcotic APIs and niche intermediates

3. Pharmaceutical Machinery & Technology Trends

Machinery and technology adoption in the region is driven by:

Key Trends

Automation & digital GMP systems

Cleanroom technologies

High-containment systems

Advanced granulation and continuous manufacturing

Sterile and oncology production technologies

Regional Market Size

Pharma machinery market (Middle East): USD 2.1B
Source: Global Process Equipment Outlook 2024

India, China, Germany, Italy, and Japan are the major suppliers.

4. Technology Transfer & Investment Opportunities

Areas of High Demand in the Region

Oncology APIs

High-potent drugs (HPAPI)

Peptides

Hormonal APIs

Sterile injectables

Packaging modernization (track & trace, smart packaging)

Why the Region Is Attractive for Partnerships

Growing regional market

Increasing regulatory harmonization

Lower production costs compared to EU

Strong government incentives (Saudi Arabia, Iran, UAE)

5. Pharmex Middle East – The Specialized Hub of the Region

Why Pharmex Matters

Pharmex Middle East is currently the only fully specialized API & machinery exhibition in the region, unlike broader healthcare expos in UAE, Turkey, and Saudi Arabia.

Core Focus of Pharmex

APIs & intermediates

Pharmaceutical machinery & production lines

Packaging solutions

Technology transfer

R&D & formulation technologies

Raw materials and excipients

Participation Statistics (2024–2025)

530+ exhibitors

20,000+ professional visitors from 20+ countries

Delegations from:

India

Russia

Uzbekistan

Algeria

China

Oman

Pakistan

Iraq

Afghanestan

Cuba

Turkey

Tajikestan

Several African markets and…

International Recognition

Listed by JETRO Japan as one of the recommended pharmaceutical exhibitions in the Middle East

Selected by Corporate Vision UK as:
“Most Influential Pharmaceutical Industry Event – Middle East (2025)”

6. Outlook for 2026–2030

Expected Regional Shifts

API localization will accelerate

Machinery imports from India & China will increase

Iran will play a central role in API & semi-finished materials

Demand for tech transfer will triple

Pharma clusters in UAE & Saudi will rely on API suppliers from Iran, India, Turkey

Role of Pharmex 2026

Become the main meeting point of the Middle Eastern supply chain

Attract 650+ companies and 25+ international delegations

Serve as the strategic bridge between Asia and the Middle East pharma industry

Sources & References

To ensure credibility, all data points cited are from publicly available international sources:

Global / Industrial

IQVIA Middle East Market Outlook 2024

UNIDO API Manufacturing Report 2023

WHO Pharmaceutical Systems Strengthening Reports

Trade Map – ITC (International Trade Centre)

Global Pharma Machinery Outlook 2024

Regional

PharmaBoardroom: Middle East 2024

Frost & Sullivan MENA Healthcare Valuation 2023

Gulf Health Council Regulatory Updates

Turkey Pharma Export Report 2024

Event-Related

JETRO (Japan External Trade Organization) – Trade Fair Listings

Corporate Vision UK – Global Business Awards 2025

Pharmex Middle East Official Post-Show Reports